Trial Profile
Prospective study to assess the emergence of drug resistance to oseltamivir following treatment of acute influenza A among children
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 02 Aug 2019
Price :
$35
*
At a glance
- Drugs Oseltamivir (Primary)
- Indications Influenza A virus infections
- Focus Therapeutic Use
- 02 Aug 2019 Status changed from active, no longer recruiting to completed.
- 04 Sep 2006 New trial record.